Co-Diagnostics Inc
(CODX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,856 | 5,413 | 950 | 2,177 | 1,528 |
| Receivables | 63 | 43 | 13 | 3 | 26 |
| Inventories | 8 | 18 | 18 | N/A | N/A |
| TOTAL | $4,560 | $5,577 | $1,052 | $2,391 | $1,780 |
| Non-Current Assets | |||||
| PPE Net | 173 | 136 | 156 | 140 | 150 |
| Investments And Advances | 585 | 408 | 345 | 182 | 39 |
| TOTAL | $758 | $544 | $501 | $323 | $190 |
| Total Assets | $5,318 | $6,121 | $1,553 | $2,713 | $1,969 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 36 | 96 | 149 | 67 | 33 |
| Accrued Expenses | 276 | 241 | 294 | 215 | 218 |
| TOTAL | $312 | $338 | $2,352 | $2,190 | $291 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 39 | 39 |
| Other Non-Current Liabilities | 200 | 220 | 260 | 270 | 300 |
| TOTAL | $200 | $220 | $260 | $396 | $436 |
| Total Liabilities | $512 | $558 | $2,612 | $2,586 | $726 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 570 | 567 | 567 | 430 | 411 |
| Common Shares | 17 | 17 | 13 | 13 | 12 |
| Retained earnings | -21,407 | -20,063 | -18,694 | -16,746 | -15,105 |
| TOTAL | $4,806 | $5,564 | $-1,059 | $127 | $1,243 |
| Total Liabilities And Equity | $5,318 | $6,121 | $1,553 | $2,713 | $1,969 |